Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Famopsin 20 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Light brown, round, film-coated tablets. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film-coated tablet contains famotidine 20 mg.
Excipient(s) with known effect:
This product contains lactose 67.4 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Famotidine |
Famotidine is a potent competitive H2-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations. |
| List of Excipients |
|---|
|
Core: Cellulose, microcrystalline Film-coating: Hypromellose |
PVC/Aluminium blisters. Pack-sizes of 30 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
11971
Date of first authorization: 12 October 1988
Date of latest renewal: 10 December 2010
| Drug | Countries | |
|---|---|---|
| FAMOPSIN | Cyprus, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
